Open access
4,694
Views
18
CrossRef citations to date
0
Altmetric
Articles
Immune correlates of clinical benefit in a phase I study of hyperthermia with adoptive T cell immunotherapy in patients with solid tumors
Guoliang QiaoDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
, Xiaoli WangDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
, Xinna ZhouDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
, Michael A. MorseDepartment of Surgery, Duke University Medical Center, Durham, NC, USA; View further author information
, Jiangping WuDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
, Shuo WangDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
, Yuguang SongDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
, Ni JiangDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
, Yanjie ZhaoDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
, Lei ZhouDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
, Jing ZhaoDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
, Yan DiDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; View further author information
, Lihong ZhuDepartment of Gynecological Oncology, Beijing Gynecology Hospital, Capital Medical University, Beijing, ChinaView further author information
, Amy HobeikaDepartment of Surgery, Duke University Medical Center, Durham, NC, USA; View further author information
, Jun RenDepartment of Medical Oncology, Beijing Key Laboratory for Therapeutic Cancer Vaccines, Capital Medical University Cancer Center, Beijing Shijitan Hospital, Capital Medical University, Beijing, China; ;Department of Surgery, Duke University Medical Center, Durham, NC, USA; Correspondence[email protected]
View further author information
& View further author information
Herbert Kim LyerlyDepartment of Surgery, Duke University Medical Center, Durham, NC, USA; Correspondence[email protected]
View further author information
show allView further author information
Pages 74-82
|
Received 28 Feb 2019, Accepted 07 Jun 2019, Published online: 03 Dec 2019
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.